<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03844230</url>
  </required_header>
  <id_info>
    <org_study_id>19294</org_study_id>
    <nct_id>NCT03844230</nct_id>
  </id_info>
  <brief_title>Role of Sweetness in Glucose Regulation</brief_title>
  <acronym>STS</acronym>
  <official_title>Role of Sweet Taste Signaling in Glucose Regulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Urbana-Champaign</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Urbana-Champaign</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Data from several studies show that consuming a diet high in low-calorie sweeteners (LCS),
      mainly in diet sodas, is linked to the same metabolic disorders as consuming a diet high in
      added sugars, including an increased risk of developing type 2 diabetes. Sweet taste
      receptors, once thought to be unique to the mouth, have now been discovered in other parts of
      the body, including the intestine and the pancreas, where they play a role in blood sugar
      control. These newly identified receptors provide new avenues to explore how LCS may affect
      metabolism and health. This project is designed to examine the role of sweet taste signaling,
      both in the mouth and in the gut, on blood sugar control and how habitual consumption of LCS
      may affect sweet taste signaling and metabolism in people with obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall goal of this research is to assess the role of oral and gut sweetness signaling
      in postprandial glucose metabolism and to determine how acute and chronic low-calorie
      sweetener (LCS) consumption may affect this signaling in people with obesity. The aims will
      determine the independent and combined contributions of pharmacological inhibition (Aim 1) or
      extra stimulation (Aim 2) of sweet taste signaling in the gut, mouth, or both on hormonal
      responses to an oral glucose tolerance test (OGTT) in two groups of subjects with obesity:
      habitual and non-habitual LCS consumers. Validated sensory evaluation techniques will also
      ascertain subjects' taste perception (Aim 3) to test the hypotheses that habitual consumption
      of LCS blunts perception of sweetness and, in turn, affects postprandial glucose regulation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 24, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Glucose</measure>
    <time_frame>Up to 5 hours after drinking a glucose load</time_frame>
    <description>Blood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma glucose concentration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Insulin</measure>
    <time_frame>Up to 5 hours after drinking a glucose load</time_frame>
    <description>Blood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma insulin concentration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma C-Peptide</measure>
    <time_frame>Up to 5 hours after drinking a glucose load</time_frame>
    <description>Blood samples will be collected before and for 5 hours after drinking a glucose load to determine plasma C-peptide concentration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensory Evaluation</measure>
    <time_frame>Up to 2 hours</time_frame>
    <description>Participants will be tasting solutions containing different concentrations of glucose, sucrose and sucralose (some of the solutions will also have lactisole) to assess their detection threshold, sweet taste intensity and preference. They will have to rate the intensity of the solution on a general Labeled Magnitude Scale (gLMS) ranging from &quot;no sensation&quot; (0) to &quot;strongest imaginable sensation&quot; (100) and choose the solutions they prefer.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Inhibition Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Randomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Inhibition, Experimental I- Inhibition, Experimental II- Inhibition). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stimulation Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Randomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Stimulation, Experimental I- Stimulation, Experimental II -Stimulation). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control - Inhibition</intervention_name>
    <description>Taste and spit up water 10 minutes before drinking a glucose load</description>
    <arm_group_label>Inhibition Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental I- Inhibition</intervention_name>
    <description>Taste and spit up water 10 minutes before drinking a glucose load mixed with lactisole</description>
    <arm_group_label>Inhibition Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental II- Inhibition</intervention_name>
    <description>Taste and spit up sucralose 10 minutes before drinking a glucose load mixed with lactisole</description>
    <arm_group_label>Inhibition Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control- Stimulation</intervention_name>
    <description>Taste and spit up water 10 minutes before drinking a glucose load</description>
    <arm_group_label>Stimulation Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental I- Stimulation</intervention_name>
    <description>Taste and spit up sucralose 10 minutes before drinking a glucose load</description>
    <arm_group_label>Stimulation Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental II- Stimulation</intervention_name>
    <description>Drink sucralose 10 minutes before drinking a glucose load</description>
    <arm_group_label>Stimulation Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sensory Evaluation</intervention_name>
    <description>Taste different solutions to evaluate sweet taste preference, suprathreshold intensity and detection threshold</description>
    <arm_group_label>Inhibition Group</arm_group_label>
    <arm_group_label>Stimulation Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All races/ethnicities

          -  Habitual (&gt; 5 diet sodas per week) and non-habitual (≤1 diet soda or 1 packet of LCS
             per week) LCS consumers

          -  30 ≤ BMI &lt;40 kg/m2

          -  Not severely insulin resistant (HOMA-IR2 &lt; 2.6)

        Exclusion Criteria:

          -  BMI &lt; 30 and 40&lt; BMI kg/m2

          -  HOMA-IR2&gt;2.6

          -  Irregular LCS consumers (&gt;1 diet sodas or packets of LCS per week but &lt;5)

          -  Current smokers or quit smoking nicotine cigarettes for less than 6 months ago

          -  Pregnant, breastfeeding, menopausal

          -  Presence of anemia : &lt;12g/dl for women and &lt;13g/dl for men

          -  Blood donation in the past 8 weeks

          -  Presence of malabsorption syndrome

          -  History of bariatric surgery

          -  Presence of inflammatory intestinal disease, liver or kidney disease

          -  Have diabetes (fasting glucose level &gt;126mg/dl or plasma glucose level 2h after
             glucose challenge &gt;200 mg/dl)

          -  Taking any medication that might affect glucose metabolism or the results of our study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marta Y Pepino, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Urbana-Champaign</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marta Y Pepino, PhD</last_name>
    <phone>(217) 300-2374</phone>
    <email>ypepino@illinois.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clara Salame, MSc, RD</last_name>
    <phone>(217) 300-4709</phone>
    <email>csalame2@illinois.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Illinois at Urbana Champaign</name>
      <address>
        <city>Champaign</city>
        <state>Illinois</state>
        <zip>61820</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Y Pepino, MSc, RD</last_name>
      <phone>217-300-2374</phone>
      <email>ypepino@illinois.edu</email>
    </contact>
    <contact_backup>
      <last_name>Clara Salame, MSc, RD</last_name>
      <phone>2178192820</phone>
      <email>csalame2@illinois.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Adams TB, Cohen SM, Doull J, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Smith RL, Waddell WJ, Wagner BM; Expert Panel of the Flavor and Extract Manufacturers Association. The FEMA GRAS assessment of phenethyl alcohol, aldehyde, acid, and related acetals and esters used as flavor ingredients. Food Chem Toxicol. 2005 Aug;43(8):1179-206. Epub 2005 Jan 26. Review.</citation>
    <PMID>15950814</PMID>
  </reference>
  <reference>
    <citation>Schiffman SS, Booth BJ, Sattely-Miller EA, Graham BG, Gibes KM. Selective inhibition of sweetness by the sodium salt of +/-2-(4-methoxyphenoxy)propanoic acid. Chem Senses. 1999 Aug;24(4):439-47.</citation>
    <PMID>10480680</PMID>
  </reference>
  <reference>
    <citation>Jiang P, Cui M, Zhao B, Liu Z, Snyder LA, Benard LM, Osman R, Margolskee RF, Max M. Lactisole interacts with the transmembrane domains of human T1R3 to inhibit sweet taste. J Biol Chem. 2005 Apr 15;280(15):15238-46. Epub 2005 Jan 24.</citation>
    <PMID>15668251</PMID>
  </reference>
  <reference>
    <citation>Karimian Azari E, Smith KR, Yi F, Osborne TF, Bizzotto R, Mari A, Pratley RE, Kyriazis GA. Inhibition of sweet chemosensory receptors alters insulin responses during glucose ingestion in healthy adults: a randomized crossover interventional study. Am J Clin Nutr. 2017 Apr;105(4):1001-1009. doi: 10.3945/ajcn.116.146001. Epub 2017 Mar 1.</citation>
    <PMID>28251932</PMID>
  </reference>
  <reference>
    <citation>Pepino MY, Tiemann CD, Patterson BW, Wice BM, Klein S. Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes Care. 2013 Sep;36(9):2530-5. doi: 10.2337/dc12-2221. Epub 2013 Apr 30.</citation>
    <PMID>23633524</PMID>
  </reference>
  <reference>
    <citation>Steinert RE, Gerspach AC, Gutmann H, Asarian L, Drewe J, Beglinger C. The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Clin Nutr. 2011 Aug;30(4):524-32. doi: 10.1016/j.clnu.2011.01.007. Epub 2011 Feb 15.</citation>
    <PMID>21324568</PMID>
  </reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 29, 2019</study_first_submitted>
  <study_first_submitted_qc>February 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2019</study_first_posted>
  <last_update_submitted>May 13, 2019</last_update_submitted>
  <last_update_submitted_qc>May 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sweeteners</keyword>
  <keyword>glucose metabolism</keyword>
  <keyword>taste receptors</keyword>
  <keyword>sucralose</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Consistent with the need to not compromise human subject protections, raw data that identifies participants will not be shared with anyone not included on our IRB approval. De-identified data, from participants who consented to share their de-identified data will be deposit in a data repository (e.g. Figshare).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>We plan to share data no later than 6 months post-publication or 18 months from the award end date per ADA expectations.</ipd_time_frame>
    <ipd_access_criteria>Data will be available to qualified individuals within the scientific community for research purposes contingent upon IRB approval for secondary data analysis.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

